Reduction in peripheral lymphocytes and thymus atrophy induced by organotin compounds in vivo

Area of Science:

• Immunotoxicology
• Environmental Health
• Cell Biology

Background:

• Organotin compounds are known environmental contaminants with potential immunotoxic effects.
• Apoptosis, or programmed cell death, is a critical process in immune system regulation and can be induced by toxic agents.
• The specific role of apoptosis in the immunotoxicity of organotins like triphenyltin (TPT) and tributyltin (TBT) requires further clarification.

Purpose of the Study:

• To investigate the involvement of apoptosis in the immunotoxicity induced by TPT and TBT in mice.
• To compare the effects of TPT and TBT on peripheral lymphocytes and thymus with dexamethasone (Dex), a known apoptosis inducer.

Main Methods:

• Mice were treated with TPT, TBT, or Dex.
• Peripheral blood lymphocytes and thymus were analyzed for cell reduction, subpopulation changes (T cells, B cells), and apoptosis/necrosis.
• Organotin levels in blood were measured, and isolated lymphocytes were incubated with organotins in vitro.

Main Results:

• TPT, TBT, and Dex caused transient peripheral lymphocyte reduction and thymus atrophy.
• TPT and TBT disproportionately reduced B cells compared to T cells.
• In vitro, high concentrations of TPT and TBT induced necrosis, with lower levels of apoptosis and necrosis at reduced concentrations.
• While Dex induced thymocyte apoptosis, TPT and TBT did not induce apoptosis or necrosis in thymocytes, suggesting antiproliferative effects caused thymus atrophy.

Conclusions:

• The study did not find evidence supporting a decisive role for apoptosis in the in vivo immunotoxicity of TPT and TBT.
• Thymus atrophy induced by TPT and TBT may be primarily due to antiproliferative mechanisms rather than apoptosis.
• Organotin compounds exhibit immunotoxic effects on lymphocytes, particularly B cells, but the mechanism is not predominantly apoptotic cell death.